MENU

Articles for GlaxoSmithKline (LSE: GSK)

Is Footsie dividend stalwart GlaxoSmithKline plc’s dividend under threat?

Here's why recent positive numbers from pharma giant GlaxoSmithKline plc (LON:GSK) may not be enough to prevent it from cutting its prized dividend. More »

Why I’d buy and hold dividend stocks GlaxoSmithKline plc & Taylor Wimpey plc

GlaxoSmithKline plc (LON: GSK) and Taylor Wimpey plc (LON: TW) could be among the best dividend payers of the next decade. More »

Are GlaxoSmithKline plc shares a bargain after FY2017 results?

GlaxoSmithKline plc (LON: GSK) currently yields 6.1% and trades on a P/E of 11.8. Does that make the shares a 'buy'? More »

Why I’d avoid this 4.5% dividend yielder and buy GlaxoSmithKline plc instead

This 4.5% dividend yielder may look attractive, but here’s why my money would go on GlaxoSmithKline plc (LON: GSK) More »

One 5% yielder I’d consider over GlaxoSmithKline plc

Are you considering alternative dividend picks amid an earnings plateau at GlaxoSmithKline plc (LON:GSK)? More »

GlaxoSmithKline plc isn’t the only Footsie dividend stock I’d buy today

Royston Wild explains why GlaxoSmithKline (LON: GSK) isn't the only income star that could make you a fortune. More »

GlaxoSmithKline plc isn’t the only unloved dividend stock I’d buy and hold forever

Roland Head explains why now could be the time to start buying GlaxoSmithKline plc (LON:GSK). More »

Why I believe you can double your money with Footsie champion GlaxoSmithKline plc

GlaxoSmithKline plc (LON: GSK) could help you double your money in 2018. More »

2 stocks I’d own during a 2018 market correction

Nervous investors may find these high-income, non-cyclical businesses great places to park their cash in 2018. More »

Why GlaxoSmithKline plc shares could be the buy of the decade

After a challenging few years, the fortunes of GlaxoSmithKline plc (LON:GSK) could be set for a dramatic improvement. More »

Should I swap GlaxoSmithKline plc for this turnaround stock?

Could this company offer higher returns than GlaxoSmithKline plc (LON:GSK)? More »

Why I would buy out-of-favour Bunzl plc over GlaxoSmithKline plc

Harvey Jones reckons Bunzl plc (LON: BNZL) could fly back into favour before fellow struggler GlaxoSmithKline plc (LON: GSK). More »

Which is the better dividend stock: Royal Dutch Shell plc or GlaxoSmithKline plc?

Royal Dutch Shell plc (LON: RDSB) and GlaxoSmithKline plc (LON: GSK) are two of the most popular dividend stocks, but does one have stronger... More »

One dividend dud I’d sell to buy GlaxoSmithKline plc

Royston Wild explains why GlaxoSmithKline plc (LON: GSK) is on course to deliver stunning shareholder returns. More »

This FTSE 100-beating investment trust could be a better buy than GlaxoSmithKline plc

Roland Head suggests a long-term alternative to FTSE 100 (INDEXFTSE:UKX) pharma giant GlaxoSmithKline plc (LON:GSK). More »

Why GlaxoSmithKline plc is my FTSE 100 stock pick for the next decade

The FTSE 100 (INDEXFTSE:UKX) is still probably the best index for long-term investors, and GlaxoSmithKline plc (LON: GSK) could be its hottest prospect right... More »

Is GlaxoSmithKline plc’s 6% dividend yield safe?

The market seems to be suggesting that GlaxoSmithKline plc's (LON: GSK) dividend will be cut. More »

Why GlaxoSmithKline plc is a growth bargain I’d buy and hold for 25 years

GlaxoSmithKline plc (LON: GSK) could be one of the best investment opportunities in the FTSE 100. More »

Is GlaxoSmithKline plc still a strong buy after Q3 results?

Bilaal Mohamed shares his views on today's third-quarter results from GlaxoSmithKline plc (LON:GSK). More »

GlaxoSmithKline plc is one of 10 top stocks for a Footsie starter portfolio

G A Chester's quarterly review of 10 FTSE 100 (INDEXFTSE:UKX) industry giants, including GlaxoSmithKline plc (LON:GSK). More »